. The company’s operating revenues range is INR 100 cr – 500 cr for the financial year ending on 31 March, 2022 ¹. The company’s consolidated net sales for September 2023 was INR 431.30 crore, up 21.63% YoY ¹².
The company’s Tofler profile reports that its authorized share capital is INR 69.00 cr and the total paid-up capital is INR 45.32 cr. Its EBITDA has increased by 12.88 % over the previous year. At the same time, its book net worth has increased by 7.45% ¹.
Please note that I am not a financial advisor and my responses are for informational purposes only. It is always advisable to consult a professional financial advisor before making any investment decisions.
Source: Conversation with Bing, 6/12/2023
(1) MARKSANS PHARMA LIMITED – Company Profile, Directors, Revenue … – Tofler. MARKSANS PHARMA LIMITED – Company Profile, Directors, Revenue & More – Tofler.
(2) Marksans Pharma Ltd Financial Results – Quarterly & Annual, Quarterly … Stock Share Price | Get Quote | BSE.
(3) Marksans Pharma Key Financial Ratios, Marksans Pharma Financial … Marksans Pharma Key Financial Ratios, Marksans Pharma Financial Statement & Accounts.
(4) Marksans Pharma Annual Reports. Marksans Pharma Annual Reports.
(5) Marksans Pharma Limited Annual Report 2022-23. http://www.marksanspharma.com/pdf/annual-report/marksans-annual-report-22-23.pdf.
| Subscribe To Our Free Newsletter |
